
Njira L Lugogo MD
Asthma & COPD
Professor of Medicine, University of Michigan
Join to view full profile
380 Parkland PlazaAnn Arbor, MI 48103
Phone+1 734-998-7380
Dr. Lugogo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Clinical Expertise
- Refractory asthma
Education & Training
Duke University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2007
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2001 - 2004
Virginia Commonwealth University School of MedicineClass of 2001
Certifications & Licensure
MI State Medical License 2017 - 2027
NC State Medical License 2001 - 2018
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Fellows Teaching Award Pulmonary Division, University of Michigan, 2019
Clinical Trials
Publications & Presentations
PubMed
- Biologic effectiveness increases with earlier biologic initiation after severe asthma onset.Arjun Mohan, Reynold A Panettieri Jr, Wendy C Moore, Njira L Lugogo, Wenjiong Zhou
The Journal of Allergy and Clinical Immunology. Global. 2026-09-01 - Reply to Zhao et al.: Clarifying structural-functional coupling by FeNO status in VESTIGE.Eleanor M Dunican, Mario Castro, Alberto Papi, Vibeke Backer, Christopher E Brightling
American Journal of Respiratory and Critical Care Medicine. 2026-08-01 - The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.William W Busse, Melissa Iammatteo, Mena Soliman, Njira L Lugogo, Leonard B Bacharier
The Journal of Allergy and Clinical Immunology. Global. 2026-07-01
Press Mentions
Breztri Gains FDA Approval as Maintenance Triple Therapy for AsthmaMay 1st, 2026
Dupilumab Reduces Airway Inflammation, Mucus Plugging in Moderate to Severe AsthmaFebruary 27th, 2024
NAVIGATOR Steers Uncontrolled Asthma Toward Calmer SeasMay 18th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









